Hormone Replacement Therapy (HRT) Market – Trends Forecast Till 2030 - PowerPoint PPT Presentation

About This Presentation
Title:

Hormone Replacement Therapy (HRT) Market – Trends Forecast Till 2030

Description:

Hormone Replacement Therapy (HRT) Market, By Product (Estrogen & Progesterone Replacement Therapy), By Route of Administration, By Disease Type and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America) – PowerPoint PPT presentation

Number of Views:0
Date added: 13 June 2024
Slides: 9
Provided by: mayuripuranik57
Category: Other
Tags:

less

Transcript and Presenter's Notes

Title: Hormone Replacement Therapy (HRT) Market – Trends Forecast Till 2030


1
Hormone Replacement Therapy (HRT) Market Trends,
Size, Share, Demands, Overview, Growth, Revenue
and Forecast to 2030
sales_at_delvens.com www.delvens.com
2
Sternal Closure Systems Market Trends Forecast
Till 2030
Hormone Replacement Therapy (HRT) Market, By
Product (Estrogen Progesterone Replacement
Therapy), By Route of Administration, By Disease
Type and Region (North America, Europe,
Asia-Pacific, Middle East and Africa and South
America).
Request For Free Sample Report
https//www.delvens.com/get-free-sample/homeland-s
ecurity-and-emergency-management-market
sales_at_delvens.com
www.delvens.com
3
Market Overview
Hormone replacement therapy is used when the
human body is not able to produce enough
hormones. It is used for the treatment of
menopause, hypothyroidism, male hypogonadism, and
growth hormone deficiency conditions. The signs
that the individual requires hormone replacement
therapy are hot flashes, night sweats, vaginal
dryness, pain, itching, or burning during
intercourse, bone loss, low sex drive, mood
changes, and irritability. The increasing
prevalence of chronic conditions such as
hypogonadism in adult men worldwide is expected
to drive the growth of the hormone replacement
therapy market. Furthermore, another major factor
fuelling the growth of the market is the ease of
access to hormonal replacement therapy and
government support for research and development
activities for hormonal replacement therapy
drugs. Purchase this Report
https//www.delvens.com/checkout/hormone-replaceme
nt-therapy-hrt-market
sales_at_delvens.com
www.delvens.com
4
Key Findings
The Hormone Replacement Therapy (HRT) Market is
segmented into product, route of administration,
disease type, and region The product segment is
further fragmented into Estrogen and Progesterone
Replacement Therapy, Human Growth Hormone (HGH)
Replacement Therapy, Thyroid Hormone Replacement
Therapy, Testosterone Replacement Therapy, and
Parathyroid Hormone Replacement. The route of
administration segment is further fragmented into
Oral, Parenteral, Transdermal, and Others.
sales_at_delvens.com
www.delvens.com
5
Key Findings
The disease segment is further fragmented into
Menopause, Hypothyroidism, Male Hypogonadism,
Growth Hormone Deficiency, and Hypoparathyroidism.
The menopause segment dominated the market and
is anticipated to maintain its dominance during
the forecast period. The market is also divided
into various regions such as North America,
Europe, Asia-Pacific, South America, and Middle
East and Africa. North America is estimated to
account for the largest market share during the
forecast period. Inquire Before Buying
https//www.delvens.com/Inquire-before-buying/horm
one-replacement-therapy-hrt-market
sales_at_delvens.com
www.delvens.com
6
Competitive Landscape
  • Novartis AG
  • Abbott Laboratories
  • Mylan N.V.
  • Merck KgaA
  • Bayer AG
  • Pfizer Inc.
  • Novo Nordisk A/S
  • QuatRx Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd.
  • Amgen, Inc.
  • Eli Lilly and Company

sales_at_delvens.com
www.delvens.com
7
Recent Developments
May 2021  Myovant Sciences GmbH announced that
it received approval from the U.S. FDA for its
hormone therapy Myfembree as a treatment for
uterine fibroid bleeding. The drug launched by
Myovant will give direct competition to AbbVie
with an added dosing advantage.  April 2021 
TherapeuticsMD, Inc. and Theramex announced that
they received approval from the Medicines and
Healthcare Products Regulatory Agency (MHRA) and
Federal Agency of Medicines and Health Products
(FAMHP) for the use of BIJUVE in the U.K and
under BIJUVA trade name in Belgium. The capsule
will be used as hormone replacement therapy.
sales_at_delvens.com
www.delvens.com
8
Contact Information
About Us Delvens is a strategic advisory and
consulting company headquartered in New Delhi,
India. The company holds expertise in providing
syndicated research reports, customized research
reports and consulting services. Delvens
qualitative and quantitative data is highly
utilized by each level from niche to major
markets, serving more than 1K prominent companies
by assuring to provide the information on
country, regional and global business
environment. We have a database for more than 45
industries in more than 115 major countries
globally. Contact Us 44-20-3290-6466 1
214-377-1144 sales_at_delvens.com
sales_at_delvens.com
www.delvens.com
Write a Comment
User Comments (0)
About PowerShow.com